Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
02/14/20 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 6
02/14/20 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 9
02/12/20 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 5
02/11/20 8-K Current report filing
Related Documents
5
02/11/20 424B4 Prospectus filed pursuant to Rule 424(b)(4) 144
02/10/20 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 7
02/10/20 8-K Current report filing
Related Documents
32
02/07/20 8-K Current report filing
Related Documents
26
02/07/20 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 13
02/06/20 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 2